COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Centers for Disease Control and Prevention released a study examining how COVID-19 is affecting American Indians and Alaska Natives — one of the populations at highest risk for the disease.
The Food and Drug Administration released a resource to help U.S. health care providers select respirators for their health care facility.
One in four U.S. counties, or 818, were COVID-19 hotspots for at least one day in the period between March 8 and July 15, representing 80% of the U.S. population, according to a report released by the Centers for Disease Control and Prevention.
The Centers for Disease Control and Prevention updated its guidance for determining when health care personnel with confirmed or suspected COVID-19 may return to work.
A test kit made by Thermo Fisher Scientific to detect COVID-19 from respiratory specimens may produce false positive results, the Food and Drug Administration warned.
FDA Saturday issued an emergency use authorization to Yale School of Public Health for a new test to detect SARS-CoV-2 in saliva.
The CDC recently released guidance for clinicians and laboratory professionals on rapid antigen testing for SARS-CoV-2.
The Food and Drug Administration will host a webinar Aug. 18 at 12 p.m. ET on its umbrella emergency use authorization for certain disposable, single use surgical masks.
U.S. adults were more likely this June than a year ago to report adverse mental health conditions, substance use and suicidal ideation, according to a report released by the Centers for Disease Control and Prevention.
The Food and Drug Administration released FAQs describing the procedures for importing respirators, face masks, and other personal protective equipment or medical devices for which the agency has issued an emergency use authorization or enforcement discretion policy during the COVID-19 pandemic.